Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2010-08-17 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
华泰联合证券有限责任公司关于公司股票上市之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is a detailed sponsorship letter from Huatai United Securities regarding the initial public offering (IPO) and stock listing of Cachet Pharmaceutical Co., Ltd. It includes comprehensive information about the company, its financial data for the past three years, issuance details, compliance with listing requirements, and the sponsor's commitments and ongoing supervision plans. The document is not a financial report like an annual or interim report, nor is it a simple announcement or certification. It is a formal underwriting and listing sponsorship document related to the company's stock listing process. This type of document fits best under the category of Capital/Financing Update (CAP), as it pertains to the company's fundraising and stock issuance activities for listing on the Shenzhen Stock Exchange.
2010-08-17 Chinese
北京市中咨律师事务所关于公司首次公开发行的股票上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the initial public offering (IPO) and listing of Jia Shi Tang Pharmaceutical Co., Ltd. It references regulatory approvals from the China Securities Regulatory Commission (CSRC) and Shenzhen Stock Exchange listing rules. The document discusses the legal qualifications, approvals, and compliance for the company's first public stock issuance and listing. It is not a financial report, earnings release, or management discussion, but a legal opinion letter supporting the IPO process. The document length is 4308 characters, which is relatively short and focused on legal opinion rather than financial data or report publication. Therefore, it fits best under Regulatory Filings (RNS) as a legal opinion related to regulatory compliance for the IPO listing, rather than a full report or announcement of voting results or capital changes.
2010-08-17 Chinese
首次公开发行股票上市公告书
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票上市公告书" which translates to "Initial Public Offering (IPO) Listing Announcement". It contains detailed information about the company's stock issuance, listing approval, shareholder structure, lock-up agreements, issuance price, subscription details, and financial data including audited and unaudited financial statements for the half-year period. The document also includes information about the controlling shareholders, management shareholdings, and other relevant disclosures related to the IPO and stock listing. It is a comprehensive announcement related to the company's initial public offering and listing on the Shenzhen Stock Exchange. This type of document is a formal announcement of the stock listing and IPO details rather than a full annual or interim financial report. It is not a typical Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a proxy, governance, or management report. Given the detailed nature and the focus on the IPO and listing, this document fits best into the category of a Regulatory Filing (RNS) as it is a formal regulatory announcement about the IPO and listing, including financial data disclosures but not a full financial report itself. The document length is substantial (15,000 characters), and it contains substantive financial data but is primarily an IPO listing announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2010-08-17 Chinese
公司章程（草案）
Governance Information Classification · 100% confidence The document is the company charter (公司章程) of 嘉事堂药业股份有限公司, dated 2009 and includes detailed provisions on company governance, shareholder rights, board structure, share issuance, shareholder meetings, and other corporate governance matters. It is a comprehensive governance document outlining the internal rules and regulations of the company. There is no indication that this is an announcement or a summary; it is the actual charter text. This type of document fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2010-08-17 Chinese
首次公开发行股票网上定价发行摇号中签结果公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement of the lottery results for the online pricing issuance of shares in the company's initial public offering (IPO). It lists the winning numbers for the share allocation lottery and instructions for investors who participated in the IPO subscription. This is not a financial report, earnings release, or management discussion. It is a capital market event related to share issuance. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and it is a direct announcement, not a report publication or regulatory filing. Confidence is high due to clear content and context.
2010-08-09 Chinese
首次公开发行A股网下配售结果公告
Capital/Financing Update Classification · 100% confidence The document is titled as a "首次公开发行A股网下配售结果公告" which translates to "Announcement of Offline Placement Results for Initial Public Offering of A-shares." It details the allocation results of shares in an IPO, including subscription amounts, allocation ratios, and lists of investors receiving shares. It references regulatory approval from the China Securities Regulatory Commission and includes detailed subscription and allocation data. This is an announcement of the results of a capital issuance (IPO) and share allocation, not a financial report or earnings release. It is not a full report but an official announcement related to capital raising and share distribution. Therefore, it fits best under the category "Capital/Financing Update (CAP)" which covers updates on company fundraising and capital structure changes.
2010-08-06 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.